BETH ISRAEL DEACONESS MEDICAL CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
- First Posted Date
- 2019-01-02
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT03791060
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT03782064
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
The Effect of Sleep Deprivation and Recovery Sleep on Emotional Memory and Affective Reactivity
- Conditions
- Interventions
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03767426
- Locations
- 🇺🇸
Tony Cunningham, Boston, Massachusetts, United States
PooR Embryo Yield Cleavage Stage Versus blaStocyst Embryo Transfer (PILOT STUDY)
- Conditions
- Interventions
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03764865
- Locations
- 🇺🇸
Boston IVF, Waltham, Massachusetts, United States
The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT03762109
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Temporal Interference Brain Stimulation
- Conditions
- Interventions
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03747601
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Open-Label Placebo for Functional Dyspepsia
- First Posted Date
- 2018-11-19
- Last Posted Date
- 2020-05-06
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT03745781
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03736421
- Locations
- 🇺🇸
St. Vincent Hospital, Worcester, Massachusetts, United States
🇺🇸Beth Israel Medical Center, Boston, Massachusetts, United States
🇺🇸University of Washington, Seattle, Washington, United States
Oxygen Therapy for Retinal Ischemia
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT03730779
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Thiamine As Adjunctive Therapy for Diabetic Ketoacidosis
- Conditions
- Interventions
- First Posted Date
- 2018-10-24
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03717896
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States